Robots make it to the healthcare conference panel, reflecting the future potential of technology
India’s bioeconomy jumped from $8 billion in 2014 to $100 billion and the country now targets $150 billion by 2025
Debut Biotechnology has outstanding enzyme search and design technology and a bio-manufacturing platform (precision fermentation, cell-free synthesis) using those enzymes
Pheezee is designed to assess musculoskeletal and neuromuscular health.
The company offers a wide portfolio of services including integrated doctor-led prescription e-commerce enablement, digital health record management, and smart clinics.
Olympus Corp was the market leader for endoscopy devices, accounting for around 23% of the global market in 2021.
Hello Patients provides healthcare billing and patients’ management solution
GlobalData’s ‘Pharmaceutical Intelligence Center’ observes that India is still in the nascent stage of developing these potential therapies as currently only four cell/gene therapy molecules are being developed in the country.
Clinikk has raised $6.4 Million so far from marquee investors such as MassMutual Ventures, 500 Startups, Times Internet and prominent angels like Kunal Shah, Rohit MA, Rajan Anandan etc.
The funds raised in the seed round will be used for research and development of Shri Chyawan Ayurved Product
Subscribe To Our Newsletter & Stay Updated
